2019 American Society of Hematology Annual Meeting*

Download All
December 7-10, 2019; Orlando, Florida
CCO’s expert faculty review and share their expert perspectives on key findings in lymphomas and chronic lymphocytic leukemia presented at the 2019 ASH annual meeting.
Jeff P. Sharman, MD

Lymphomas and Chronic Lymphocytic Leukemia

Are you aware of the latest clinical data in CLL and lymphomas? In this commentary, Jeff P. Sharman, MD, discusses 5 key studies on CLL/lymphomas that were recently presented at ASH 2019.

Jeff P. Sharman, MD Released: January 23, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower in partnership with Clinical Care Options.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Celgene Corporation
Dova Pharmaceuticals, Inc.
Karyopharm Therapeutics
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings